Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

High-Dose Vitamin D3 Supplementation in the Treatment of Human Immune Deficiency Virus Patients: A Double-Blind Randomized Control Trial

NCT05306704 is registered in ClinicalTrials.gov with University of the Punjab as lead sponsor.

NCT NCT05306704
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05306704 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
High-Dose Vitamin D3 Supplementation in the Treatment of Human Immune Deficiency Virus Patients: A Double-Blind Randomized Control Trial
Lead sponsor
University of the Punjab
Phase
Phase 3
Overall status
Completed
Start date
February 15, 2019
Completion date
January 31, 2022
Enrollment
95 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hiv-1-infection, hypovitaminosis d